Gene Symbol | Gene ID | Gene Info |
---|---|---|
AHR
|
ENSG00000106546.8 | aryl hydrocarbon receptor |
ARNT2
|
ENSG00000172379.14 | aryl hydrocarbon receptor nuclear translocator 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_80696981_80697364 | ARNT2 | 479 | 0.729458 | 0.85 | 3.5e-03 | Click! |
chr15_80696331_80696627 | ARNT2 | 214 | 0.792915 | 0.70 | 3.5e-02 | Click! |
chr15_80697546_80697697 | ARNT2 | 928 | 0.515770 | 0.34 | 3.7e-01 | Click! |
chr15_80705502_80705653 | ARNT2 | 8884 | 0.192615 | 0.30 | 4.3e-01 | Click! |
chr15_80697368_80697519 | ARNT2 | 750 | 0.587843 | 0.28 | 4.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_3842280_3842488 | 2.94 |
LRRN1 |
leucine rich repeat neuronal 1 |
1263 |
0.64 |
chr17_78913033_78913504 | 2.90 |
CTD-2561B21.4 |
|
2565 |
0.19 |
chr13_114909025_114909176 | 2.78 |
RASA3 |
RAS p21 protein activator 3 |
11014 |
0.22 |
chr17_80273697_80273867 | 2.73 |
CD7 |
CD7 molecule |
1646 |
0.24 |
chr1_109642870_109643021 | 2.60 |
ENSG00000270066 |
. |
130 |
0.93 |
chr21_45230405_45230556 | 2.33 |
AP001053.11 |
|
238 |
0.92 |
chr19_18314394_18314545 | 2.33 |
RAB3A |
RAB3A, member RAS oncogene family |
353 |
0.7 |
chr10_43361894_43362113 | 2.24 |
ENSG00000252416 |
. |
34005 |
0.18 |
chr18_43913300_43913541 | 2.22 |
RNF165 |
ring finger protein 165 |
511 |
0.87 |
chr13_114821671_114821822 | 2.07 |
RASA3 |
RAS p21 protein activator 3 |
21692 |
0.22 |
chr19_57276797_57277174 | 2.06 |
AC006115.3 |
|
244 |
0.92 |
chr17_80290906_80291105 | 2.05 |
SECTM1 |
secreted and transmembrane 1 |
633 |
0.57 |
chr6_167368882_167369033 | 1.98 |
RP11-514O12.4 |
|
655 |
0.54 |
chr11_64533116_64533267 | 1.95 |
SF1 |
splicing factor 1 |
1898 |
0.22 |
chr12_24715215_24715566 | 1.94 |
ENSG00000240481 |
. |
144332 |
0.05 |
chr22_47172138_47172381 | 1.92 |
TBC1D22A |
TBC1 domain family, member 22A |
2435 |
0.29 |
chr15_75091800_75092051 | 1.91 |
CSK |
c-src tyrosine kinase |
1670 |
0.24 |
chr4_7940832_7940983 | 1.88 |
AC097381.1 |
|
179 |
0.87 |
chr2_103420061_103420470 | 1.88 |
TMEM182 |
transmembrane protein 182 |
41793 |
0.19 |
chr6_36646575_36646743 | 1.84 |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
161 |
0.94 |
chr19_1266927_1267078 | 1.83 |
CIRBP |
cold inducible RNA binding protein |
85 |
0.93 |
chr18_57364004_57364155 | 1.78 |
RP11-2N1.2 |
|
388 |
0.58 |
chr19_2052424_2052697 | 1.76 |
MKNK2 |
MAP kinase interacting serine/threonine kinase 2 |
1317 |
0.28 |
chr9_115142694_115142927 | 1.74 |
HSDL2 |
hydroxysteroid dehydrogenase like 2 |
418 |
0.87 |
chr12_58166621_58166991 | 1.72 |
RP11-571M6.15 |
Uncharacterized protein |
30 |
0.64 |
chr19_54041083_54041240 | 1.72 |
ZNF331 |
zinc finger protein 331 |
172 |
0.91 |
chr2_222435646_222435870 | 1.71 |
EPHA4 |
EPH receptor A4 |
1245 |
0.41 |
chr19_3360665_3360877 | 1.71 |
NFIC |
nuclear factor I/C (CCAAT-binding transcription factor) |
1090 |
0.51 |
chr11_61061797_61061948 | 1.70 |
VWCE |
von Willebrand factor C and EGF domains |
1024 |
0.42 |
chr15_33010315_33010466 | 1.68 |
GREM1 |
gremlin 1, DAN family BMP antagonist |
185 |
0.95 |
chr16_31488502_31488862 | 1.66 |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
3935 |
0.1 |
chr15_37391319_37391470 | 1.64 |
MEIS2 |
Meis homeobox 2 |
113 |
0.55 |
chr10_126303814_126303965 | 1.63 |
FAM53B-AS1 |
FAM53B antisense RNA 1 |
88305 |
0.08 |
chr14_51560821_51560990 | 1.63 |
TRIM9 |
tripartite motif containing 9 |
889 |
0.62 |
chr4_47487771_47488087 | 1.63 |
ATP10D |
ATPase, class V, type 10D |
613 |
0.76 |
chr3_46933845_46934001 | 1.62 |
AC109583.1 |
Uncharacterized protein |
3752 |
0.17 |
chr17_42907747_42907965 | 1.62 |
GJC1 |
gap junction protein, gamma 1, 45kDa |
257 |
0.87 |
chr1_61548208_61548523 | 1.61 |
NFIA |
nuclear factor I/A |
30 |
0.95 |
chr5_159698543_159698722 | 1.61 |
ENSG00000243654 |
. |
20163 |
0.16 |
chr3_66024738_66024948 | 1.60 |
MAGI1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
618 |
0.77 |
chr1_246888014_246888165 | 1.60 |
SCCPDH |
saccharopine dehydrogenase (putative) |
740 |
0.68 |
chr22_20785559_20785830 | 1.59 |
SCARF2 |
scavenger receptor class F, member 2 |
6418 |
0.12 |
chr20_61426843_61427110 | 1.59 |
MRGBP |
MRG/MORF4L binding protein |
829 |
0.47 |
chr5_134369071_134369280 | 1.58 |
C5orf66 |
chromosome 5 open reading frame 66 |
205 |
0.67 |
chr11_45101428_45101680 | 1.57 |
PRDM11 |
PR domain containing 11 |
14010 |
0.27 |
chr6_2990600_2990762 | 1.57 |
NQO2 |
NAD(P)H dehydrogenase, quinone 2 |
1801 |
0.27 |
chr8_99953508_99953739 | 1.55 |
STK3 |
serine/threonine kinase 3 |
1176 |
0.44 |
chr12_58021297_58021508 | 1.55 |
B4GALNT1 |
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
1110 |
0.28 |
chr9_136734785_136735088 | 1.54 |
VAV2 |
vav 2 guanine nucleotide exchange factor |
122467 |
0.05 |
chr4_103997575_103997726 | 1.54 |
SLC9B2 |
solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 |
161 |
0.96 |
chr1_207262773_207263064 | 1.54 |
C4BPB |
complement component 4 binding protein, beta |
31 |
0.97 |
chr22_45809669_45809983 | 1.51 |
RIBC2 |
RIB43A domain with coiled-coils 2 |
252 |
0.57 |
chr1_26453922_26454389 | 1.50 |
PDIK1L |
PDLIM1 interacting kinase 1 like |
15815 |
0.1 |
chr10_81964386_81964537 | 1.50 |
ANXA11 |
annexin A11 |
214 |
0.94 |
chr15_89922425_89922697 | 1.49 |
ENSG00000207819 |
. |
11313 |
0.19 |
chr22_19566523_19566737 | 1.49 |
CLDN5 |
claudin 5 |
51562 |
0.11 |
chr17_31727_31878 | 1.48 |
DOC2B |
double C2-like domains, beta |
375 |
0.89 |
chr8_24813592_24813772 | 1.48 |
CTD-2168K21.2 |
|
453 |
0.84 |
chr1_204043106_204043302 | 1.48 |
SOX13 |
SRY (sex determining region Y)-box 13 |
50 |
0.98 |
chr15_75940359_75940571 | 1.47 |
SNX33 |
sorting nexin 33 |
218 |
0.75 |
chr5_130500369_130500520 | 1.46 |
HINT1 |
histidine triad nucleotide binding protein 1 |
505 |
0.84 |
chr13_26760426_26760577 | 1.46 |
RNF6 |
ring finger protein (C3H2C3 type) 6 |
35339 |
0.2 |
chr10_135191922_135192261 | 1.46 |
PAOX |
polyamine oxidase (exo-N4-amino) |
604 |
0.42 |
chr11_121322176_121322327 | 1.46 |
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
661 |
0.66 |
chr5_77147520_77147686 | 1.45 |
TBCA |
tubulin folding cofactor A |
17001 |
0.28 |
chr6_82462618_82462948 | 1.45 |
FAM46A |
family with sequence similarity 46, member A |
292 |
0.91 |
chr8_99960797_99961016 | 1.44 |
OSR2 |
odd-skipped related transciption factor 2 |
286 |
0.9 |
chr1_26095948_26096099 | 1.44 |
SEPN1 |
selenoprotein N, 1 |
30644 |
0.1 |
chr15_77925542_77925770 | 1.43 |
LINGO1 |
leucine rich repeat and Ig domain containing 1 |
824 |
0.63 |
chr21_38446268_38446486 | 1.43 |
TTC3 |
tetratricopeptide repeat domain 3 |
787 |
0.41 |
chr16_3208356_3208515 | 1.43 |
CASP16 |
caspase 16, apoptosis-related cysteine peptidase (putative) |
14191 |
0.08 |
chr19_51520457_51520740 | 1.42 |
KLK10 |
kallikrein-related peptidase 10 |
2422 |
0.11 |
chr5_153569409_153569665 | 1.42 |
GALNT10 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) |
753 |
0.75 |
chr11_60738879_60739030 | 1.42 |
CD6 |
CD6 molecule |
161 |
0.92 |
chr17_2698592_2698793 | 1.42 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
1040 |
0.51 |
chr3_157815509_157815676 | 1.41 |
SHOX2 |
short stature homeobox 2 |
7491 |
0.25 |
chr11_75919123_75919322 | 1.41 |
WNT11 |
wingless-type MMTV integration site family, member 11 |
1646 |
0.38 |
chr7_19155701_19156072 | 1.41 |
TWIST1 |
twist family bHLH transcription factor 1 |
1409 |
0.34 |
chr16_1822722_1822873 | 1.40 |
MRPS34 |
mitochondrial ribosomal protein S34 |
354 |
0.43 |
chr9_139622784_139622935 | 1.40 |
SNHG7 |
small nucleolar RNA host gene 7 (non-protein coding) |
223 |
0.83 |
chr10_11287980_11288168 | 1.40 |
CELF2-AS1 |
CELF2 antisense RNA 1 |
73773 |
0.1 |
chr21_46898650_46899022 | 1.40 |
COL18A1 |
collagen, type XVIII, alpha 1 |
11353 |
0.2 |
chr1_118198098_118198249 | 1.37 |
ENSG00000212266 |
. |
33191 |
0.18 |
chrX_153598459_153598772 | 1.36 |
FLNA |
filamin A, alpha |
1036 |
0.31 |
chr16_81772024_81772176 | 1.36 |
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
602 |
0.83 |
chr13_27132297_27132561 | 1.35 |
WASF3 |
WAS protein family, member 3 |
542 |
0.86 |
chr20_61591319_61591493 | 1.35 |
SLC17A9 |
solute carrier family 17 (vesicular nucleotide transporter), member 9 |
7008 |
0.16 |
chr8_74884890_74885153 | 1.35 |
TCEB1 |
transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) |
499 |
0.73 |
chr6_2783346_2783497 | 1.34 |
WRNIP1 |
Werner helicase interacting protein 1 |
14414 |
0.19 |
chr2_73151273_73151429 | 1.34 |
EMX1 |
empty spiracles homeobox 1 |
234 |
0.94 |
chr19_19651883_19652039 | 1.34 |
CILP2 |
cartilage intermediate layer protein 2 |
2887 |
0.16 |
chr13_53313519_53313861 | 1.33 |
LECT1 |
leukocyte cell derived chemotaxin 1 |
203 |
0.96 |
chr1_235668123_235668390 | 1.33 |
B3GALNT2 |
beta-1,3-N-acetylgalactosaminyltransferase 2 |
475 |
0.86 |
chr2_54950292_54950443 | 1.33 |
EML6 |
echinoderm microtubule associated protein like 6 |
1312 |
0.48 |
chr6_74405273_74405424 | 1.33 |
CD109 |
CD109 molecule |
160 |
0.82 |
chr2_233406378_233406593 | 1.32 |
CHRNG |
cholinergic receptor, nicotinic, gamma (muscle) |
2027 |
0.18 |
chr19_45624716_45624879 | 1.32 |
AC005757.6 |
|
15438 |
0.09 |
chr9_34579054_34579205 | 1.32 |
CNTFR-AS1 |
CNTFR antisense RNA 1 |
9540 |
0.1 |
chr15_59042528_59042890 | 1.32 |
ADAM10 |
ADAM metallopeptidase domain 10 |
532 |
0.73 |
chr11_721788_721980 | 1.31 |
AP006621.9 |
|
5163 |
0.09 |
chr14_103244886_103245037 | 1.31 |
TRAF3 |
TNF receptor-associated factor 3 |
1006 |
0.54 |
chr9_99983679_99983884 | 1.31 |
CCDC180 |
coiled-coil domain containing 180 |
16984 |
0.22 |
chr7_156811014_156811206 | 1.31 |
MNX1-AS1 |
MNX1 antisense RNA 1 (head to head) |
7611 |
0.17 |
chr17_59488896_59489087 | 1.30 |
RP11-332H18.4 |
|
75 |
0.56 |
chr11_57243945_57244096 | 1.30 |
RP11-624G17.3 |
|
987 |
0.35 |
chr6_109416777_109417181 | 1.30 |
CEP57L1 |
centrosomal protein 57kDa-like 1 |
214 |
0.88 |
chr10_131988762_131988934 | 1.29 |
GLRX3 |
glutaredoxin 3 |
54185 |
0.18 |
chr19_47733345_47733548 | 1.29 |
BBC3 |
BCL2 binding component 3 |
1005 |
0.44 |
chr18_9990302_9990453 | 1.29 |
ENSG00000263630 |
. |
14817 |
0.22 |
chr6_41341429_41341783 | 1.29 |
ENSG00000238867 |
. |
18419 |
0.17 |
chr10_33623994_33624145 | 1.29 |
NRP1 |
neuropilin 1 |
63 |
0.98 |
chr22_42373254_42373515 | 1.29 |
SEPT3 |
septin 3 |
390 |
0.75 |
chr11_65172568_65172719 | 1.28 |
FRMD8 |
FERM domain containing 8 |
18244 |
0.1 |
chr14_94427996_94428222 | 1.28 |
ASB2 |
ankyrin repeat and SOCS box containing 2 |
4342 |
0.18 |
chr1_228674208_228674396 | 1.28 |
RNF187 |
ring finger protein 187 |
460 |
0.64 |
chr4_57371914_57372065 | 1.28 |
ARL9 |
ADP-ribosylation factor-like 9 |
480 |
0.79 |
chr15_70552699_70552850 | 1.28 |
ENSG00000200216 |
. |
67199 |
0.14 |
chr16_55534003_55534240 | 1.27 |
LPCAT2 |
lysophosphatidylcholine acyltransferase 2 |
8789 |
0.21 |
chr13_52390546_52391185 | 1.27 |
RP11-327P2.5 |
|
12432 |
0.19 |
chr1_183774405_183774704 | 1.27 |
RGL1 |
ral guanine nucleotide dissociation stimulator-like 1 |
264 |
0.94 |
chr22_45073925_45074076 | 1.26 |
PRR5 |
proline rich 5 (renal) |
1035 |
0.57 |
chr1_218519256_218519556 | 1.26 |
TGFB2 |
transforming growth factor, beta 2 |
171 |
0.75 |
chr9_92092219_92092635 | 1.25 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
2378 |
0.35 |
chr19_30266391_30266542 | 1.25 |
CCNE1 |
cyclin E1 |
36339 |
0.19 |
chr5_73937413_73937691 | 1.25 |
ENC1 |
ectodermal-neural cortex 1 (with BTB domain) |
303 |
0.88 |
chr19_37263183_37263454 | 1.25 |
ZNF850 |
zinc finger protein 850 |
398 |
0.64 |
chr11_67414259_67414491 | 1.25 |
ACY3 |
aspartoacylase (aminocyclase) 3 |
679 |
0.53 |
chr10_23983491_23983716 | 1.24 |
KIAA1217 |
KIAA1217 |
72 |
0.99 |
chr10_130938879_130939133 | 1.24 |
MGMT |
O-6-methylguanine-DNA methyltransferase |
326442 |
0.01 |
chr22_51111449_51111608 | 1.24 |
SHANK3 |
SH3 and multiple ankyrin repeat domains 3 |
1315 |
0.29 |
chr8_110552359_110552510 | 1.24 |
EBAG9 |
estrogen receptor binding site associated, antigen, 9 |
28 |
0.98 |
chr2_112895548_112895716 | 1.23 |
FBLN7 |
fibulin 7 |
330 |
0.92 |
chr17_1171868_1172019 | 1.23 |
BHLHA9 |
basic helix-loop-helix family, member a9 |
1910 |
0.31 |
chr1_221914225_221914505 | 1.23 |
DUSP10 |
dual specificity phosphatase 10 |
1096 |
0.67 |
chrX_149530829_149530999 | 1.23 |
MAMLD1 |
mastermind-like domain containing 1 |
637 |
0.82 |
chr10_135088104_135088270 | 1.22 |
ADAM8 |
ADAM metallopeptidase domain 8 |
2167 |
0.17 |
chr7_72349768_72349919 | 1.22 |
POM121 |
POM121 transmembrane nucleoporin |
93 |
0.95 |
chr3_71631893_71632155 | 1.22 |
FOXP1 |
forkhead box P1 |
880 |
0.62 |
chr11_1854004_1854332 | 1.21 |
SYT8 |
synaptotagmin VIII |
1485 |
0.24 |
chr17_43325543_43325694 | 1.21 |
CTD-2020K17.4 |
|
88 |
0.74 |
chr17_77179648_77179799 | 1.21 |
RBFOX3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
169 |
0.96 |
chr21_38445924_38446075 | 1.21 |
TTC3 |
tetratricopeptide repeat domain 3 |
409 |
0.54 |
chr5_56205875_56206117 | 1.20 |
SETD9 |
SET domain containing 9 |
64 |
0.89 |
chr13_100835367_100835518 | 1.20 |
PCCA |
propionyl CoA carboxylase, alpha polypeptide |
94105 |
0.08 |
chr1_205425192_205425343 | 1.20 |
LEMD1 |
LEM domain containing 1 |
6208 |
0.17 |
chr20_3073916_3074245 | 1.20 |
ENSG00000263905 |
. |
781 |
0.5 |
chr1_151131154_151131481 | 1.20 |
SCNM1 |
sodium channel modifier 1 |
2177 |
0.13 |
chr7_134896674_134896838 | 1.19 |
WDR91 |
WD repeat domain 91 |
440 |
0.78 |
chr11_112833162_112833366 | 1.19 |
RP11-629G13.1 |
|
918 |
0.43 |
chr19_50931332_50931483 | 1.19 |
MYBPC2 |
myosin binding protein C, fast type |
4753 |
0.1 |
chr14_70654341_70654492 | 1.19 |
RP11-486O13.2 |
|
576 |
0.7 |
chr13_80913383_80913664 | 1.18 |
SPRY2 |
sprouty homolog 2 (Drosophila) |
271 |
0.95 |
chr11_3244430_3244621 | 1.18 |
MRGPRG-AS1 |
MRGPRG antisense RNA 1 |
1620 |
0.25 |
chr10_135054594_135055053 | 1.18 |
VENTX |
VENT homeobox |
3915 |
0.13 |
chr16_3415255_3415501 | 1.18 |
MTRNR2L4 |
MT-RNR2-like 4 |
6905 |
0.11 |
chr19_54345571_54345878 | 1.18 |
NLRP12 |
NLR family, pyrin domain containing 12 |
18076 |
0.05 |
chr7_127807200_127807456 | 1.17 |
ENSG00000207705 |
. |
40596 |
0.15 |
chr9_78506329_78506658 | 1.17 |
PCSK5 |
proprotein convertase subtilisin/kexin type 5 |
872 |
0.69 |
chr9_123691540_123691691 | 1.17 |
TRAF1 |
TNF receptor-associated factor 1 |
164 |
0.96 |
chr21_36261605_36261866 | 1.17 |
RUNX1 |
runt-related transcription factor 1 |
299 |
0.95 |
chr7_32801823_32802076 | 1.17 |
ENSG00000207573 |
. |
29356 |
0.19 |
chr13_42036673_42037077 | 1.16 |
RGCC |
regulator of cell cycle |
5180 |
0.17 |
chr21_46170002_46170153 | 1.16 |
TSPEAR |
thrombospondin-type laminin G domain and EAR repeats |
38582 |
0.08 |
chr17_56407049_56407274 | 1.16 |
BZRAP1-AS1 |
BZRAP1 antisense RNA 1 |
195 |
0.84 |
chr9_140149303_140149480 | 1.16 |
NELFB |
negative elongation factor complex member B |
234 |
0.79 |
chr1_37979370_37979521 | 1.15 |
MEAF6 |
MYST/Esa1-associated factor 6 |
425 |
0.78 |
chr10_134330835_134330986 | 1.15 |
LINC01165 |
long intergenic non-protein coding RNA 1165 |
5043 |
0.22 |
chr9_139741211_139741362 | 1.15 |
PHPT1 |
phosphohistidine phosphatase 1 |
1890 |
0.13 |
chr10_119133925_119134076 | 1.15 |
PDZD8 |
PDZ domain containing 8 |
978 |
0.6 |
chr1_239551368_239551626 | 1.15 |
CHRM3 |
cholinergic receptor, muscarinic 3 |
240876 |
0.02 |
chr2_97438269_97438433 | 1.15 |
CNNM4 |
cyclin M4 |
11712 |
0.15 |
chr22_40390022_40390173 | 1.14 |
FAM83F |
family with sequence similarity 83, member F |
856 |
0.59 |
chr10_8101306_8101484 | 1.14 |
GATA3 |
GATA binding protein 3 |
4626 |
0.36 |
chr19_38894202_38894438 | 1.14 |
FAM98C |
family with sequence similarity 98, member C |
511 |
0.6 |
chrX_154696753_154696904 | 1.14 |
TMLHE-AS1 |
TMLHE antisense RNA 1 |
627 |
0.51 |
chr5_179780667_179780893 | 1.14 |
GFPT2 |
glutamine-fructose-6-phosphate transaminase 2 |
393 |
0.88 |
chr1_156085465_156085736 | 1.14 |
LMNA |
lamin A/C |
1087 |
0.35 |
chr16_79804143_79804372 | 1.14 |
ENSG00000221330 |
. |
100623 |
0.08 |
chr22_37822407_37822558 | 1.13 |
RP1-63G5.5 |
|
998 |
0.35 |
chr19_2079915_2080066 | 1.13 |
MOB3A |
MOB kinase activator 3A |
1272 |
0.31 |
chr4_1294223_1294440 | 1.13 |
MAEA |
macrophage erythroblast attacher |
8900 |
0.15 |
chr5_60627093_60627244 | 1.13 |
ZSWIM6 |
zinc finger, SWIM-type containing 6 |
932 |
0.71 |
chr2_225906606_225906766 | 1.13 |
DOCK10 |
dedicator of cytokinesis 10 |
473 |
0.87 |
chr16_68877967_68878205 | 1.12 |
TANGO6 |
transport and golgi organization 6 homolog (Drosophila) |
577 |
0.73 |
chr22_47010676_47010986 | 1.12 |
GRAMD4 |
GRAM domain containing 4 |
5468 |
0.26 |
chr12_122230457_122230608 | 1.12 |
RHOF |
ras homolog family member F (in filopodia) |
734 |
0.62 |
chr17_80476920_80477151 | 1.12 |
FOXK2 |
forkhead box K2 |
556 |
0.63 |
chr7_48075453_48075673 | 1.12 |
C7orf57 |
chromosome 7 open reading frame 57 |
446 |
0.83 |
chr5_9544937_9545108 | 1.11 |
SEMA5A |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
1165 |
0.47 |
chr17_78577061_78577320 | 1.11 |
RPTOR |
regulatory associated protein of MTOR, complex 1 |
57922 |
0.13 |
chr7_105711154_105711314 | 1.11 |
SYPL1 |
synaptophysin-like 1 |
27074 |
0.22 |
chr17_36719686_36719966 | 1.10 |
SRCIN1 |
SRC kinase signaling inhibitor 1 |
166 |
0.94 |
chr16_58534602_58534753 | 1.10 |
NDRG4 |
NDRG family member 4 |
627 |
0.62 |
chr1_25363513_25363668 | 1.10 |
ENSG00000264371 |
. |
13596 |
0.23 |
chr8_145149461_145149643 | 1.10 |
CYC1 |
cytochrome c-1 |
378 |
0.68 |
chr3_38388272_38388423 | 1.10 |
XYLB |
xylulokinase homolog (H. influenzae) |
1 |
0.98 |
chr6_3229015_3229236 | 1.09 |
TUBB2B |
tubulin, beta 2B class IIb |
1156 |
0.44 |
chr20_42939356_42939507 | 1.09 |
FITM2 |
fat storage-inducing transmembrane protein 2 |
378 |
0.8 |
chr1_3514916_3515113 | 1.09 |
MEGF6 |
multiple EGF-like-domains 6 |
13045 |
0.13 |
chr22_47011623_47011860 | 1.09 |
GRAMD4 |
GRAM domain containing 4 |
4558 |
0.27 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.7 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.9 | 2.6 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.8 | 2.5 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.8 | 3.8 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.7 | 2.9 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.7 | 2.8 | GO:0072189 | ureter development(GO:0072189) |
0.7 | 2.0 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.7 | 2.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.7 | 2.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.6 | 0.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.6 | 1.9 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.6 | 1.8 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.6 | 1.8 | GO:0090009 | primitive streak formation(GO:0090009) |
0.6 | 2.9 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.6 | 1.7 | GO:0010761 | fibroblast migration(GO:0010761) |
0.6 | 1.7 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.6 | 0.6 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.6 | 2.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.5 | 1.1 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.5 | 1.6 | GO:0061054 | dermatome development(GO:0061054) |
0.5 | 2.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.5 | 1.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.5 | 2.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.5 | 1.5 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.5 | 0.5 | GO:0045844 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.5 | 0.9 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.5 | 0.9 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.5 | 2.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.5 | 1.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 0.5 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.5 | 2.3 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.5 | 2.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.5 | 1.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.5 | 2.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.5 | 2.3 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.5 | 0.9 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.5 | 2.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 1.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.4 | 1.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.4 | 1.8 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.4 | 1.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 1.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.4 | 1.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.4 | 1.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 1.6 | GO:0001553 | luteinization(GO:0001553) |
0.4 | 0.4 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.4 | 1.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.4 | 0.8 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.4 | 2.4 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.4 | 1.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.4 | 0.8 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.4 | 0.8 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.4 | 1.9 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 0.8 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.4 | 0.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.4 | 1.5 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.4 | 2.3 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.4 | 2.3 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.4 | 3.8 | GO:0051322 | anaphase(GO:0051322) |
0.4 | 1.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.4 | 1.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 1.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 0.4 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.4 | 2.6 | GO:0015886 | heme transport(GO:0015886) |
0.4 | 1.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.4 | 1.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.4 | 1.8 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.4 | 0.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.4 | 1.4 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.4 | 0.4 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.4 | 0.4 | GO:0048143 | astrocyte activation(GO:0048143) |
0.3 | 0.7 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 0.3 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.3 | 1.0 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.3 | 1.4 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 0.3 | GO:0031269 | pseudopodium organization(GO:0031268) pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 1.0 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.3 | 2.8 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.3 | 1.0 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.3 | 1.4 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.3 | 1.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 1.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.3 | 0.3 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.3 | 1.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 1.0 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.3 | 1.0 | GO:0032661 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.3 | 0.6 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.3 | 1.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 1.3 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.3 | 0.3 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.3 | 0.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.3 | 0.6 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 1.9 | GO:0060251 | regulation of glial cell proliferation(GO:0060251) |
0.3 | 0.6 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 0.3 | GO:0006168 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.3 | 0.6 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.3 | 2.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 0.9 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 1.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 0.3 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.3 | 0.9 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 1.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 0.3 | GO:0001570 | vasculogenesis(GO:0001570) |
0.3 | 0.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 0.3 | GO:0072070 | loop of Henle development(GO:0072070) |
0.3 | 0.9 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 0.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.3 | 3.5 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.3 | 1.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.3 | 0.9 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.3 | 2.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 0.3 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.3 | 0.9 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 1.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.3 | 0.6 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.3 | 2.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 1.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 0.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.3 | 1.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.3 | 1.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.8 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.3 | 1.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.3 | 0.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 0.8 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.3 | 0.3 | GO:0090192 | regulation of glomerulus development(GO:0090192) |
0.3 | 1.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 0.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 0.3 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.3 | 0.3 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.3 | 0.5 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.3 | 0.5 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.3 | 0.8 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 0.8 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.3 | 1.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.3 | 0.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 1.0 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 1.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 0.8 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.3 | 0.5 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 0.5 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.3 | 0.3 | GO:0043276 | anoikis(GO:0043276) |
0.3 | 0.3 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.3 | 0.8 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.3 | 0.8 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 0.5 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.3 | 1.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 1.0 | GO:0014002 | astrocyte development(GO:0014002) |
0.3 | 0.8 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.3 | 1.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 1.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 2.5 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.2 | 0.2 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.2 | 0.7 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.2 | 1.7 | GO:0033483 | gas homeostasis(GO:0033483) |
0.2 | 1.7 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 0.5 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 0.7 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.2 | 0.2 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.2 | 0.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 1.2 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.2 | 1.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 1.2 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.2 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.9 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 0.9 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.2 | 0.5 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 0.5 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.2 | 0.7 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.2 | 0.7 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.2 | 1.6 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.2 | 0.7 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 0.7 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.4 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 0.7 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 1.6 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.2 | 2.0 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.4 | GO:0090037 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 0.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.2 | 1.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 0.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.9 | GO:0033197 | response to vitamin E(GO:0033197) |
0.2 | 1.3 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.7 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.2 | 1.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.4 | GO:0015809 | arginine transport(GO:0015809) |
0.2 | 0.6 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.2 | 0.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 0.2 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.2 | 1.3 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.2 | 2.7 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.2 | 0.2 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.2 | 0.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.4 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.2 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.6 | GO:0021853 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.2 | 1.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 0.8 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.2 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.6 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.2 | 0.6 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.2 | 1.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.4 | GO:0032825 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 2.0 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.2 | 0.4 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.2 | 0.4 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.2 | 2.4 | GO:0006386 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.2 | 1.0 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 0.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.4 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.2 | 1.0 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 0.6 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.2 | 0.6 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.2 | 0.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 3.0 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.2 | 1.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.6 | GO:0017085 | response to insecticide(GO:0017085) |
0.2 | 1.8 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.2 | 1.9 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.2 | 0.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.4 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.2 | 0.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.2 | 1.3 | GO:0007172 | signal complex assembly(GO:0007172) |
0.2 | 0.6 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.2 | 0.4 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.2 | 1.0 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.2 | 0.2 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.2 | 0.6 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 0.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 1.1 | GO:0007498 | mesoderm development(GO:0007498) |
0.2 | 0.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 2.1 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 0.7 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.2 | 0.9 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.2 | 0.7 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.6 | GO:0006188 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.2 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 0.9 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 0.2 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.2 | 0.2 | GO:2000647 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) negative regulation of stem cell proliferation(GO:2000647) |
0.2 | 2.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.9 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.2 | 1.8 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.2 | 1.5 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 0.9 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 0.5 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 0.4 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.2 | 0.4 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 0.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 1.3 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 0.5 | GO:0001885 | endothelial cell development(GO:0001885) |
0.2 | 0.9 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 0.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 0.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 1.6 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.2 | 0.5 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.2 | 0.3 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.2 | 0.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.5 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.2 | 0.2 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.2 | 0.5 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.2 | 1.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.5 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.2 | 0.5 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.2 | 0.3 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 0.5 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.7 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.7 | GO:0009750 | response to fructose(GO:0009750) |
0.2 | 1.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 0.3 | GO:0002118 | aggressive behavior(GO:0002118) |
0.2 | 0.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 0.2 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.2 | 0.3 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.2 | 0.5 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.2 | 0.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.5 | GO:0001893 | maternal placenta development(GO:0001893) |
0.2 | 0.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 1.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.3 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.2 | 0.5 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.2 | 1.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 0.8 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.2 | 0.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 0.3 | GO:0060346 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.2 | 1.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 1.3 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
0.2 | 1.6 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.2 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.2 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 1.5 | GO:0090114 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.2 | 0.5 | GO:0042640 | anagen(GO:0042640) |
0.2 | 0.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 0.3 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.2 | 0.6 | GO:0008354 | germ cell migration(GO:0008354) |
0.2 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 1.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 0.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 2.4 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 0.6 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.2 | 0.5 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.2 | 0.3 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.2 | 0.3 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 0.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.3 | GO:0009648 | photoperiodism(GO:0009648) |
0.2 | 0.2 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.2 | 0.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.3 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.2 | 0.8 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 2.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 1.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.6 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 0.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 0.6 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 1.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 2.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.9 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 1.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 1.6 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.1 | 0.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 1.3 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.7 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.3 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.1 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 0.7 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.1 | 0.4 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.1 | 0.1 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.1 | 0.4 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 0.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 1.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.4 | GO:0003407 | neural retina development(GO:0003407) |
0.1 | 0.4 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.7 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.6 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.1 | 0.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.3 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.6 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 2.0 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.1 | GO:0034311 | sphinganine metabolic process(GO:0006667) diol metabolic process(GO:0034311) |
0.1 | 0.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.8 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.4 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.1 | 1.0 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 2.0 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 1.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.3 | GO:0009309 | amine biosynthetic process(GO:0009309) |
0.1 | 0.5 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 3.6 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 0.8 | GO:1901998 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 0.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.3 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.3 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.1 | 0.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.7 | GO:0060323 | head morphogenesis(GO:0060323) |
0.1 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 2.3 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.5 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.4 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 1.1 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.1 | 0.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.1 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
0.1 | 0.3 | GO:0051208 | sequestering of calcium ion(GO:0051208) |
0.1 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.8 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.1 | 0.7 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.4 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 0.7 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 3.1 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.4 | GO:1903504 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.4 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.1 | 0.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 1.6 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 1.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.3 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 0.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
0.1 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 2.9 | GO:0051318 | G1 phase(GO:0051318) |
0.1 | 0.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.4 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.1 | 0.3 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.8 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.1 | 0.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.1 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.8 | GO:0031345 | negative regulation of cell projection organization(GO:0031345) |
0.1 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.3 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.1 | 1.3 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.4 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.8 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.1 | 0.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 2.2 | GO:1901799 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.1 | 0.6 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 1.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.7 | GO:0006906 | vesicle fusion(GO:0006906) |
0.1 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.9 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.9 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 0.2 | GO:0010939 | regulation of necrotic cell death(GO:0010939) |
0.1 | 0.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.6 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 1.0 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 1.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.4 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 1.1 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.2 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.2 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.1 | 1.0 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 0.2 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.1 | 1.4 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 2.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 1.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 2.5 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 0.2 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.4 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.5 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 1.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.2 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.5 | GO:0006309 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
0.1 | 2.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.7 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.1 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.2 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.3 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.5 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.1 | 2.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.1 | 0.8 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 2.3 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 2.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.7 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.3 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.1 | 1.6 | GO:1990266 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.1 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 1.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 2.0 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 7.4 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.3 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.1 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.1 | 0.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 1.2 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.1 | 0.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.8 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 0.1 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.1 | 12.6 | GO:0070085 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) glycosylation(GO:0070085) |
0.1 | 0.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) negative regulation of receptor activity(GO:2000272) |
0.1 | 0.4 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.8 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 1.3 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.1 | 0.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 1.0 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.1 | 0.7 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.9 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.3 | GO:0032392 | DNA geometric change(GO:0032392) |
0.1 | 0.1 | GO:0090329 | regulation of DNA-dependent DNA replication(GO:0090329) |
0.1 | 0.3 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 1.3 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.5 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.8 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.1 | GO:0021517 | ventral spinal cord development(GO:0021517) spinal cord motor neuron differentiation(GO:0021522) |
0.1 | 0.3 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 2.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.7 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 1.0 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.5 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.2 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 1.8 | GO:0043928 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.1 | 0.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0097581 | lamellipodium organization(GO:0097581) |
0.1 | 0.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.5 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.1 | GO:0014909 | smooth muscle cell migration(GO:0014909) |
0.1 | 0.3 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 1.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 1.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.5 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.1 | 0.4 | GO:1903556 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 0.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 1.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 2.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.5 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 6.2 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.1 | GO:1901990 | regulation of mitotic cell cycle phase transition(GO:1901990) |
0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 1.1 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.6 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.2 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 0.1 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.1 | 0.2 | GO:0042219 | sulfur amino acid catabolic process(GO:0000098) cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.1 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.1 | 1.0 | GO:0045143 | synapsis(GO:0007129) homologous chromosome segregation(GO:0045143) chromosome organization involved in meiotic cell cycle(GO:0070192) |
0.1 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.1 | GO:0002285 | lymphocyte activation involved in immune response(GO:0002285) |
0.1 | 0.2 | GO:0001774 | microglial cell activation(GO:0001774) microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.5 | GO:0071322 | cellular response to carbohydrate stimulus(GO:0071322) |
0.1 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.1 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.1 | 0.5 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 3.0 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 1.4 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.4 | GO:0010559 | regulation of glycoprotein biosynthetic process(GO:0010559) regulation of glycoprotein metabolic process(GO:1903018) |
0.1 | 0.6 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.1 | 2.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.1 | GO:0001756 | somitogenesis(GO:0001756) |
0.1 | 0.6 | GO:0090278 | negative regulation of peptide secretion(GO:0002792) negative regulation of peptide hormone secretion(GO:0090278) |
0.1 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 13.9 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 0.5 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 3.0 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) actin-mediated cell contraction(GO:0070252) |
0.1 | 0.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.4 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 0.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.4 | GO:0015879 | quaternary ammonium group transport(GO:0015697) amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 3.8 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.7 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.1 | 0.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.1 | 0.3 | GO:0051917 | regulation of fibrinolysis(GO:0051917) |
0.1 | 0.6 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.3 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.1 | 0.4 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.2 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.2 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.4 | GO:0050704 | regulation of interleukin-1 secretion(GO:0050704) |
0.1 | 0.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.2 | GO:0033345 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.1 | 0.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.5 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) aspartate transport(GO:0015810) |
0.1 | 0.8 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 1.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.4 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 5.1 | GO:0050657 | RNA localization(GO:0006403) nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
0.1 | 1.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 1.1 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.1 | 0.2 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.1 | 0.9 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.1 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.2 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.7 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.2 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.3 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 1.2 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.1 | 0.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 1.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.3 | GO:0032200 | telomere organization(GO:0032200) |
0.1 | 1.8 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.6 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.6 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.1 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
0.1 | 0.1 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.1 | 0.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 2.8 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 1.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.5 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.1 | 0.7 | GO:0043174 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) nucleoside salvage(GO:0043174) |
0.1 | 0.2 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.1 | GO:0072176 | nephric duct development(GO:0072176) mesonephric duct development(GO:0072177) nephric duct morphogenesis(GO:0072178) mesonephric duct morphogenesis(GO:0072180) |
0.1 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.9 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.1 | 0.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.2 | GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade(GO:0070304) |
0.1 | 0.2 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 1.7 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 0.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 1.4 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.4 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 1.6 | GO:0044247 | polysaccharide catabolic process(GO:0000272) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.7 | GO:0000279 | M phase(GO:0000279) |
0.1 | 0.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.8 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 1.1 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.3 | GO:0043491 | protein kinase B signaling(GO:0043491) |
0.1 | 0.2 | GO:0001914 | regulation of T cell mediated cytotoxicity(GO:0001914) |
0.1 | 0.1 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.1 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0095500 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 2.9 | GO:0007254 | JNK cascade(GO:0007254) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.2 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 0.2 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 2.3 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.1 | 0.6 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.3 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.8 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 1.7 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.6 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.1 | GO:2001234 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.1 | 0.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 5.4 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.2 | GO:0090502 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) cleavage involved in rRNA processing(GO:0000469) endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) maturation of SSU-rRNA(GO:0030490) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 2.2 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.1 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.3 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.7 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.1 | GO:0045010 | actin nucleation(GO:0045010) |
0.1 | 0.8 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 1.9 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.1 | 1.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 1.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.3 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0035113 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.1 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 2.8 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 1.1 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.3 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.7 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 1.9 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 4.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.3 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
0.1 | 0.2 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.9 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 9.8 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.1 | 0.5 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.1 | 0.1 | GO:0046824 | positive regulation of nucleocytoplasmic transport(GO:0046824) |
0.1 | 10.8 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.2 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.1 | 0.3 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.3 | GO:0031929 | TOR signaling(GO:0031929) |
0.1 | 0.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.2 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.1 | 0.3 | GO:1901215 | negative regulation of neuron apoptotic process(GO:0043524) negative regulation of neuron death(GO:1901215) |
0.1 | 0.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.4 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.4 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 5.7 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.1 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.1 | 7.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.2 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 0.2 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.1 | 0.1 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.1 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 1.5 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.1 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.2 | GO:0009071 | glycine catabolic process(GO:0006546) serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.2 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.1 | 0.5 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.1 | 0.1 | GO:0071674 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.1 | 0.2 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.1 | 0.2 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.5 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.1 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.1 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 1.0 | GO:0030509 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.9 | GO:0009799 | specification of symmetry(GO:0009799) |
0.1 | 0.3 | GO:0050860 | regulation of T cell receptor signaling pathway(GO:0050856) negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.9 | GO:0007259 | JAK-STAT cascade(GO:0007259) STAT cascade(GO:0097696) |
0.1 | 0.1 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.1 | 0.1 | GO:0032609 | interferon-gamma production(GO:0032609) regulation of interferon-gamma production(GO:0032649) |
0.1 | 0.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 1.2 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.6 | GO:0045333 | cellular respiration(GO:0045333) |
0.1 | 0.2 | GO:0070997 | neuron death(GO:0070997) |
0.1 | 0.1 | GO:0031669 | cellular response to nutrient levels(GO:0031669) |
0.1 | 0.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.6 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.1 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 1.8 | GO:0016055 | Wnt signaling pathway(GO:0016055) cell-cell signaling by wnt(GO:0198738) |
0.1 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.1 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 1.6 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 1.7 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 1.1 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) histone lysine methylation(GO:0034968) |
0.1 | 0.2 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.1 | GO:0030878 | thyroid gland development(GO:0030878) |
0.1 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.1 | 0.1 | GO:0071514 | genetic imprinting(GO:0071514) |
0.1 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 1.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.1 | GO:0042991 | regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
0.1 | 0.1 | GO:0014904 | myotube cell development(GO:0014904) skeletal muscle fiber development(GO:0048741) |
0.1 | 0.3 | GO:0001838 | embryonic epithelial tube formation(GO:0001838) |
0.1 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.4 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.1 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.1 | 0.1 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.1 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.1 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.8 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.1 | 0.1 | GO:1903299 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.9 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.3 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.1 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 5.3 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 1.0 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.1 | 0.7 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.1 | 0.1 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 0.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.5 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.0 | 0.2 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.2 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.1 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.0 | 0.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.6 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.1 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.3 | GO:0050868 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.0 | 0.2 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.0 | 0.4 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 4.7 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.4 | GO:0051789 | obsolete response to protein(GO:0051789) |
0.0 | 0.0 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.6 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 0.2 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 1.6 | GO:0007126 | meiotic nuclear division(GO:0007126) meiotic cell cycle process(GO:1903046) |
0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.2 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.1 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 1.5 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.0 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.8 | GO:0051302 | regulation of cell division(GO:0051302) |
0.0 | 0.3 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.0 | 0.0 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.3 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.0 | 0.3 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.1 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.0 | 0.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.2 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.3 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.0 | GO:0002832 | negative regulation of response to biotic stimulus(GO:0002832) |
0.0 | 0.5 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.0 | 0.0 | GO:1990138 | axon extension(GO:0048675) neuron projection extension(GO:1990138) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 1.4 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.0 | 0.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.0 | 0.5 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 1.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0090174 | organelle membrane fusion(GO:0090174) |
0.0 | 1.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 4.9 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.0 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.0 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.3 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 2.1 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.9 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 0.8 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.0 | 0.0 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.5 | GO:0044782 | cilium organization(GO:0044782) |
0.0 | 0.0 | GO:0042326 | negative regulation of phosphorylation(GO:0042326) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0060192 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.0 | 0.1 | GO:0032277 | regulation of gonadotropin secretion(GO:0032276) negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.8 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.0 | 1.3 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.0 | GO:0060479 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.0 | 2.8 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 3.0 | GO:0016311 | dephosphorylation(GO:0016311) |
0.0 | 0.1 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.0 | 0.4 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.0 | GO:0010522 | regulation of calcium ion transport into cytosol(GO:0010522) |
0.0 | 0.1 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.3 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.4 | GO:0006606 | protein import into nucleus(GO:0006606) protein targeting to nucleus(GO:0044744) single-organism nuclear import(GO:1902593) |
0.0 | 0.0 | GO:0035107 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.0 | 0.4 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 8.7 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.5 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.0 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.2 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.2 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.0 | 0.1 | GO:0044319 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.0 | 0.1 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.0 | 0.0 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 1.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.3 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.0 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.4 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.3 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.0 | 0.1 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.6 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.3 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.0 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.3 | GO:0099504 | synaptic vesicle cycle(GO:0099504) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 5.0 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.0 | 0.7 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 1.0 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.0 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.0 | 0.5 | GO:0060070 | canonical Wnt signaling pathway(GO:0060070) |
0.0 | 0.1 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 2.0 | GO:0007034 | vacuolar transport(GO:0007034) |
0.0 | 0.0 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.0 | 0.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.0 | GO:0032202 | telomere assembly(GO:0032202) telomere formation via telomerase(GO:0032203) |
0.0 | 0.1 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.0 | 0.1 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 1.3 | GO:0045786 | negative regulation of cell cycle(GO:0045786) |
0.0 | 0.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.0 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 1.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.0 | GO:0033673 | negative regulation of kinase activity(GO:0033673) |
0.0 | 0.0 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.0 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.1 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.1 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.0 | 0.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.1 | GO:0048645 | organ formation(GO:0048645) |
0.0 | 0.4 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.0 | 0.0 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.0 | 0.0 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.1 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 0.1 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.0 | 0.1 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.0 | 0.1 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.0 | 0.3 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.2 | GO:0009100 | glycoprotein metabolic process(GO:0009100) |
0.0 | 0.0 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) |
0.0 | 0.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.0 | 0.0 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.4 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.0 | GO:0055006 | cardiac cell development(GO:0055006) cardiac muscle cell development(GO:0055013) |
0.0 | 0.0 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.0 | 0.0 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.0 | GO:0021915 | neural tube development(GO:0021915) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.3 | GO:0048863 | stem cell differentiation(GO:0048863) |
0.0 | 0.0 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.0 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.0 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.3 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.1 | GO:0032368 | regulation of lipid transport(GO:0032368) |
0.0 | 0.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.0 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.1 | GO:0006302 | double-strand break repair(GO:0006302) |
0.0 | 0.1 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.0 | 18.9 | GO:0016070 | RNA metabolic process(GO:0016070) |
0.0 | 0.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 1.3 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.0 | GO:0043393 | regulation of protein binding(GO:0043393) |
0.0 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.0 | GO:0000819 | sister chromatid segregation(GO:0000819) |
0.0 | 0.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.0 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 1.0 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.1 | GO:0030104 | water homeostasis(GO:0030104) |
0.0 | 0.2 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.1 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.1 | GO:0044241 | lipid digestion(GO:0044241) |
0.0 | 0.4 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.0 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.0 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 0.2 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.0 | GO:0015853 | adenine transport(GO:0015853) |
0.0 | 0.0 | GO:0043112 | receptor metabolic process(GO:0043112) |
0.0 | 0.0 | GO:0060173 | appendage development(GO:0048736) limb development(GO:0060173) |
0.0 | 0.1 | GO:0043410 | positive regulation of MAPK cascade(GO:0043410) |
0.0 | 0.0 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.0 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.1 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.0 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:1903651 | positive regulation of cytoplasmic transport(GO:1903651) |
0.0 | 0.3 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.4 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.0 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.0 | GO:0050870 | positive regulation of homotypic cell-cell adhesion(GO:0034112) positive regulation of T cell activation(GO:0050870) positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.5 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0018209 | peptidyl-serine modification(GO:0018209) |
0.0 | 4.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.1 | GO:0042246 | tissue regeneration(GO:0042246) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 1.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.5 | 0.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.4 | 2.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 0.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.4 | 2.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.4 | 1.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.3 | 1.0 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.3 | 2.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 1.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 0.3 | GO:0044427 | chromosomal part(GO:0044427) |
0.3 | 1.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 0.9 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.3 | 0.9 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 0.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 0.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 1.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 3.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.3 | 0.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 1.3 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 1.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 1.0 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 1.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 0.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 1.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.7 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 1.4 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.2 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 2.4 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.2 | 0.2 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.2 | 3.6 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.2 | 1.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 1.5 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.2 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 4.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 2.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 3.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 0.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 1.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 1.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 0.6 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.2 | 1.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 2.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 3.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 2.4 | GO:0043189 | H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 0.6 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 0.6 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 2.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.7 | GO:0032059 | bleb(GO:0032059) |
0.2 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.2 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 1.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 1.3 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 2.9 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.2 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 1.2 | GO:0000792 | heterochromatin(GO:0000792) |
0.2 | 0.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 0.5 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
0.2 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.3 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.1 | 5.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 10.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 2.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.3 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.4 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.8 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 3.3 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 1.5 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.5 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.1 | 0.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 2.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.6 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.1 | 1.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.6 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.1 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.5 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.9 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 1.3 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 0.7 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.4 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 9.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 1.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 2.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 1.2 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 3.9 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 1.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 4.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 2.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 1.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 1.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.3 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 1.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 2.4 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.6 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.5 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 8.1 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 2.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 2.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 6.2 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.9 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 1.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 6.7 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.6 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 1.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 3.5 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.4 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 7.6 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.5 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 8.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.9 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 6.8 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.1 | 0.5 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.0 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 2.1 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.2 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 9.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 3.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 4.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 2.2 | GO:0030427 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
0.1 | 0.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 10.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.4 | GO:0030990 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.1 | 2.7 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 1.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.5 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.8 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 1.2 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 3.0 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.2 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.1 | 5.9 | GO:0005819 | spindle(GO:0005819) |
0.1 | 1.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.1 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 1.2 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 2.0 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 8.5 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 5.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 2.6 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 1.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 2.1 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.1 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 5.3 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.1 | 0.3 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.3 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 5.0 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.1 | 1.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.1 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 2.1 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 3.2 | GO:0098562 | cytoplasmic side of plasma membrane(GO:0009898) cytoplasmic side of membrane(GO:0098562) |
0.1 | 0.4 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 3.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.9 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 4.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 51.9 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.8 | GO:0005792 | obsolete microsome(GO:0005792) |
0.1 | 0.4 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 1.3 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) anaphase-promoting complex(GO:0005680) |
0.1 | 6.3 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 14.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 9.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 56.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 1.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.1 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 177.4 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 18.6 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 0.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.3 | GO:0012505 | endomembrane system(GO:0012505) |
0.1 | 0.1 | GO:0044304 | main axon(GO:0044304) |
0.1 | 0.6 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.1 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.2 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.1 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 1.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 1.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.1 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.0 | 0.5 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.0 | GO:1990234 | transferase complex(GO:1990234) |
0.0 | 0.0 | GO:0031090 | organelle membrane(GO:0031090) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 3.5 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 1.5 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 6.7 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.0 | 6.7 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.0 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.0 | 26.8 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.4 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0031982 | vesicle(GO:0031982) |
0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.2 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.7 | GO:0097223 | acrosomal vesicle(GO:0001669) sperm part(GO:0097223) |
0.0 | 0.0 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.3 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 3.9 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.1 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 2.3 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 15.2 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 0.2 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 41.7 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 1.9 | GO:0098590 | plasma membrane region(GO:0098590) |
0.0 | 56.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.2 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.0 | GO:0016272 | prefoldin complex(GO:0016272) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.6 | 1.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.6 | 2.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.6 | 2.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.5 | 1.6 | GO:0005113 | patched binding(GO:0005113) |
0.5 | 2.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.5 | 1.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.5 | 1.4 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.5 | 1.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.4 | 1.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 0.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.4 | 2.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.4 | 0.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.4 | 1.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 1.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 0.8 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.4 | 1.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.4 | 2.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 1.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 1.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 1.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 2.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 2.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 1.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 0.7 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.3 | 1.7 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.3 | 2.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 1.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.3 | 1.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 1.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 1.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.3 | 1.3 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 0.6 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.3 | 1.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 1.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 1.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 1.3 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 1.6 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 0.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 4.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 0.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 0.9 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.3 | 1.8 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 2.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 0.9 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 1.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 0.9 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 0.9 | GO:0004875 | complement receptor activity(GO:0004875) |
0.3 | 2.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 0.9 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.3 | 1.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 0.9 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 0.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 1.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 1.7 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.3 | 0.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 1.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.3 | 1.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 1.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 0.8 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.3 | 0.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.3 | 2.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.3 | 1.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.3 | 1.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 4.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.3 | 1.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 0.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 1.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 2.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 0.8 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.3 | 1.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.3 | 5.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.3 | 0.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 0.8 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.3 | 0.5 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 1.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.3 | 1.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 0.5 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 1.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.7 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 3.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 0.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.2 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.9 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 1.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.5 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 1.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.9 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 0.7 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 3.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 1.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 2.3 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.2 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 1.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 2.9 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 0.4 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.2 | 0.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 1.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 1.5 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.2 | 2.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 0.6 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.2 | 0.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 1.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 3.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 1.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 1.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 0.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 0.8 | GO:0015184 | sulfur amino acid transmembrane transporter activity(GO:0000099) L-cystine transmembrane transporter activity(GO:0015184) |
0.2 | 1.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.6 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.2 | 0.6 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.2 | 1.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 2.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 1.2 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) phosphatidylinositol 3-kinase activity(GO:0035004) |
0.2 | 1.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 0.6 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.2 | 2.0 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.2 | 2.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 2.0 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 1.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 2.3 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.2 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 1.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.2 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 2.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 2.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 1.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 0.9 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 0.6 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.8 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 1.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.7 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 2.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 1.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 5.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 1.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 1.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 0.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 1.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.2 | 0.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.5 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.2 | 0.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 1.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 1.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 0.9 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 0.9 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.2 | 1.6 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.2 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.4 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
0.2 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.5 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.2 | 1.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 1.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 1.4 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 1.7 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 1.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 1.0 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 1.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.2 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) single base insertion or deletion binding(GO:0032138) single guanine insertion binding(GO:0032142) oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.2 | 0.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 1.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 1.2 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.2 | 1.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 1.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 2.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.7 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.2 | 2.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 0.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.5 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 0.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 0.6 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.2 | 0.5 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.2 | 0.8 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 1.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 3.0 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.2 | 0.5 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.5 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.2 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.2 | 1.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.5 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 1.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.2 | 1.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.2 | 0.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.6 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.2 | 1.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 1.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 1.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 1.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 3.7 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 3.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.4 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 2.5 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 1.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.1 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
0.1 | 0.8 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 1.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.8 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.1 | 1.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 1.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.6 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.1 | 1.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.4 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.3 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 1.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 1.5 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 1.1 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 0.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 2.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.9 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 3.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.1 | 2.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.8 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 1.0 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.4 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.1 | 0.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 10.0 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 2.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 2.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 1.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.5 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.4 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 27.0 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.1 | 1.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 1.4 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.1 | 0.6 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.5 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 3.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 2.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 3.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.2 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 1.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.4 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.8 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 2.6 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 3.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 1.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.2 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.1 | 0.3 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.2 | GO:0070008 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
0.1 | 1.2 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.1 | 0.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.3 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 1.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.6 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.4 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 1.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.4 | GO:0051020 | GTPase binding(GO:0051020) |
0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 2.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 2.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.7 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 3.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.2 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 1.7 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.3 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.1 | 0.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 4.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 4.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 1.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 2.5 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 2.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 1.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 1.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 1.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.4 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 0.5 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 3.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 1.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 1.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 4.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.2 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.6 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 1.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.3 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 1.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.3 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 2.8 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 1.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 1.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.1 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.2 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 2.3 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 2.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 1.9 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 4.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 1.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.8 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.2 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 0.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.2 | GO:0046970 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.1 | 2.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.2 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.1 | 1.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 1.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.2 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.1 | 0.1 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 7.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 5.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 1.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.1 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.1 | 19.4 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 1.1 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 1.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.5 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.3 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 1.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 2.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.9 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.3 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.1 | 1.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 1.4 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 0.4 | GO:0046527 | UDP-glucosyltransferase activity(GO:0035251) glucosyltransferase activity(GO:0046527) |
0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 1.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 2.4 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 1.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 1.6 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 7.3 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.1 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 5.1 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.1 | 1.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.2 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 1.0 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.1 | 0.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 1.5 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.2 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.1 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 6.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.6 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 1.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 2.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 1.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 1.9 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.8 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 7.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 0.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 102.4 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.6 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0050662 | coenzyme binding(GO:0050662) |
0.0 | 0.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 1.6 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 0.5 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.0 | 7.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.5 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 9.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.5 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 1.0 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.0 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.0 | 0.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 1.3 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.0 | 0.1 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 1.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.2 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 1.2 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.8 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.8 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.0 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.0 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.5 | GO:1901681 | sulfur compound binding(GO:1901681) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.0 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 0.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.4 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 3.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0008144 | drug binding(GO:0008144) |
0.0 | 0.1 | GO:0048406 | neurotrophin binding(GO:0043121) nerve growth factor binding(GO:0048406) |
0.0 | 0.3 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 11.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.5 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 1.8 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 1.0 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.0 | 0.0 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.3 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 4.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.2 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 1.3 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 1.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 0.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.4 | GO:0016747 | transferase activity, transferring acyl groups other than amino-acyl groups(GO:0016747) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.0 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.0 | GO:0016715 | dopamine beta-monooxygenase activity(GO:0004500) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.0 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.0 | 0.3 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 51.2 | GO:0005515 | protein binding(GO:0005515) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.3 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.0 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.6 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.0 | 0.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.0 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.1 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.1 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.0 | 0.1 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.0 | 0.0 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.5 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.0 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0022834 | ligand-gated ion channel activity(GO:0015276) ligand-gated channel activity(GO:0022834) |
0.0 | 4.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 1.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 3.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 2.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 1.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 3.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 9.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 1.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 3.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 1.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 2.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 2.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 5.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 1.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 1.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 10.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 3.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 1.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 12.6 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 2.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 0.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 6.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 4.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 1.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 3.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 1.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 1.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 5.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 6.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 4.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 4.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 1.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 3.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 4.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 3.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 2.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 8.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 3.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 2.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 7.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 3.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 2.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 2.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 5.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 2.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 2.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.8 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.0 | PID ATM PATHWAY | ATM pathway |
0.1 | 2.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 2.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 2.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 7.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.7 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 3.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.0 | PID IL27 PATHWAY | IL27-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 1.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.7 | 0.7 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.4 | 3.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 4.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 4.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 3.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 0.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.3 | 1.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 3.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 4.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 2.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 2.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 2.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 3.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 3.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 2.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 2.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 3.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 6.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 1.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 3.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 1.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 1.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 4.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 5.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 0.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 3.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 2.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 0.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 2.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 6.5 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 0.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 0.2 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 0.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 0.2 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.2 | 1.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 1.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 3.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 2.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 3.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 1.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 1.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 2.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 1.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 1.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 1.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 5.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 9.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 2.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 1.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 3.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 0.3 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 1.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 0.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 2.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 1.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 0.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 2.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 4.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.7 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 1.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 6.6 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 1.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 3.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 2.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 3.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.8 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 1.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 1.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 3.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.2 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 2.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 2.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 3.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 2.3 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
0.1 | 2.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 3.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.7 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 2.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 3.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 3.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION | Genes involved in TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
0.1 | 3.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 1.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 2.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 1.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 2.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 8.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 4.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 25.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 1.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 5.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.3 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 1.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.7 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.1 | 0.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 3.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.5 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 2.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.7 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.2 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 3.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 1.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 2.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 3.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 4.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.3 | REACTOME MAP KINASE ACTIVATION IN TLR CASCADE | Genes involved in MAP kinase activation in TLR cascade |
0.1 | 0.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 2.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.4 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 0.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 1.0 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.3 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 2.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 1.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.4 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.4 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 1.0 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 2.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 1.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 1.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.1 | REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE | Genes involved in NFkB and MAP kinases activation mediated by TLR4 signaling repertoire |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.9 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.0 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 4.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 2.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.0 | REACTOME S PHASE | Genes involved in S Phase |
0.0 | 1.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.7 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.2 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 2.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.0 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.0 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 4.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |